Park DM - Search Results

1

Improving the radiosensitivity of radioresistant and hypoxic glioblastoma.

Sheehan JP, Shaffrey ME, Gupta B, Larner J, Rich JN, Park DM. Sheehan JP, et al. Among authors: park dm. Future Oncol. 2010 Oct;6(10):1591-601. doi: 10.2217/fon.10.123. Future Oncol. 2010. PMID: 21062158 Review.

2

Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma.

Jung J, Zhang Y, Celiku O, Zhang W, Song H, Williams BJ, Giles AJ, Rich JN, Abounader R, Gilbert MR, Park DM. Jung J, et al. Among authors: park dm. Cancer Res. 2019 Oct 15;79(20):5218-5232. doi: 10.1158/0008-5472.CAN-19-0198. Epub 2019 Sep 5. Cancer Res. 2019. PMID: 31488423 Free PMC article.

3

Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor.

Sheehan JP, Popp B, Monteith S, Toulmin S, Tomlinson J, Martin J, Cifarelli CP, Lee DH, Park DM. Sheehan JP, et al. Among authors: park dm. J Neurosurg. 2011 Oct;115(4):749-53. doi: 10.3171/2011.5.JNS101954. Epub 2011 Jun 17. J Neurosurg. 2011. PMID: 21682571

4

Biology of glioma cancer stem cells.

Park DM, Rich JN. Park DM, et al. Mol Cells. 2009 Jul 31;28(1):7-12. doi: 10.1007/s10059-009-0111-2. Epub 2009 Jul 20. Mol Cells. 2009. PMID: 19655094 Free article. Review.

5

Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery.

Williams BJ, Park DM, Sheehan JP. Williams BJ, et al. Among authors: park dm. J Neurosurg. 2012 May;116(5):972-7. doi: 10.3171/2012.1.JNS111627. Epub 2012 Feb 10. J Neurosurg. 2012. PMID: 22324417

6

Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma.

Lee DH, Zhang Y, Kassam AB, Park MJ, Gardner P, Prevedello D, Henry S, Horbinski C, Beumer JH, Tawbi H, Williams BJ, Shaffrey ME, Egorin MJ, Abounader R, Park DM. Lee DH, et al. Among authors: park mj, park dm. PLoS One. 2015 Aug 6;10(8):e0134426. doi: 10.1371/journal.pone.0134426. eCollection 2015. PLoS One. 2015. PMID: 26247786 Free PMC article.

7

Medical oncology: treatment and management of malignant gliomas.

Park DM, Sathornsumetee S, Rich JN. Park DM, et al. Nat Rev Clin Oncol. 2010 Feb;7(2):75-7. doi: 10.1038/nrclinonc.2009.221. Nat Rev Clin Oncol. 2010. PMID: 20118976 No abstract available.

8

The evidence of glioblastoma heterogeneity.

Soeda A, Hara A, Kunisada T, Yoshimura S, Iwama T, Park DM. Soeda A, et al. Among authors: park dm. Sci Rep. 2015 Jan 27;5:7979. doi: 10.1038/srep07979. Sci Rep. 2015. PMID: 25623281 Free PMC article.

9

Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells.

Colwell N, Larion M, Giles AJ, Seldomridge AN, Sizdahkhani S, Gilbert MR, Park DM. Colwell N, et al. Among authors: park dm. Neuro Oncol. 2017 Jul 1;19(7):887-896. doi: 10.1093/neuonc/now258. Neuro Oncol. 2017. PMID: 28339582 Free PMC article. Review.

10

The p38 signaling pathway mediates quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking.

Soeda A, Lathia J, Williams BJ, Wu Q, Gallagher J, Androutsellis-Theotokis A, Giles AJ, Yang C, Zhuang Z, Gilbert MR, Rich JN, Park DM. Soeda A, et al. Among authors: park dm. Oncotarget. 2017 May 16;8(20):33316-33328. doi: 10.18632/oncotarget.16741. Oncotarget. 2017. PMID: 28410196 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page